Halozyme (HALO) EBITDA margin US GAAP (year values) |
||||||||
2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
EBITDA margin, % | ? | 57.2% | 58.4% | 47.8% | 47.8% | 54.5% | 60.2% | |
Changes by years, y/y, % | +86pp | +1pp | -11pp | 0pp | +7pp |
Halozyme. EBITDA margin, %
Halozyme. EBITDA margin, changes, pp
Halozyme (HALO) EBITDA margin US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
EBITDA margin, % | ? | 59.9% | 55.2% | 59.1% | 59.5% | 65.5% | 60.2% | |
Changes by years, y/y, % | +6pp | +12pp | +15pp | +7pp | +6pp | |||
Changes by quarters, q/q, % | +8pp | -5pp | +4pp | +0pp | +6pp |